Dendrimer a versatile polymer in drug delivery

被引:7
|
作者
Singh, Shakti K. [1 ]
Lohiya, G. K. [1 ]
Limburkar, P. P. [1 ]
Dharbale, N. B. [1 ]
Mourya, V. K. [1 ]
机构
[1] Govt Coll Pharm, Opp Govt, Dept Pharmaceut, Polytech, Aurangabad, Maharashtra, India
关键词
Biomaterials; dendrimer; drug delivery; nanoscopic drug carriers; polyamidoamine (PAMAM) dendrimer;
D O I
10.4103/0973-8398.56295
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dendrimers are a unique class of synthetic macromolecules having highly branched, three-dimensional, nanoscale architecture with very low polydispersity and high functionality. Structural advantages allow dendrimers to play an important role in the fields of nanotechnology, pharmaceutical and medicinal chemistry. This review discusses several aspects of dendrimers, including preparation, dendrimer-drug coupling chemistry, structural models of dendrimer-based drug delivery systems, and physicochemical and toxicological properties. Dendrimers have emerged as one of the most interesting themes for researchers as a result of their unique architecture and macromolecular characteristics. Several groups are involved in exploring their potential as versatile carriers in drug delivery. The use of dendrimers in drug delivery has been reviewed extensively. The increasing relevance of the potential of dendrimers in drug delivery emphasizes the need to explore the routes by which they can be administered. The high level of control possible over the architectural design of dendrimers; their size, shape, branching length/density, and their surface functionality clearly distinguish these structures as unique and optimum carriers in those applications. The bioactive agents may be encapsulated into the interior of the dendrimers or chemically attached/physically adsorbed onto the dendrimer surface, with the option of tailoring the carrier to the specific needs of the active material and its therapeutic applications. This review clearly demonstrates the potential of this new fourth major class of polymer architecture and indeed substantiates the high hopes for the future of dendrimers.
引用
收藏
页码:178 / 187
页数:10
相关论文
共 50 条
  • [41] Versatile composite hydrogels for drug delivery and beyond
    Chiang, Yi-Hua
    Wu, Meng-Ju
    Hsu, Wei-Chin
    Hu, Teh-Min
    JOURNAL OF MATERIALS CHEMISTRY B, 2020, 8 (38) : 8830 - 8837
  • [42] Unstructured polypeptides as a versatile drug delivery technology
    Ji, Yue
    Liu, Dingkang
    Zhu, Haichao
    Bao, Lichen
    Chang, Ruilong
    Gao, Xiangdong
    Yin, Jun
    ACTA BIOMATERIALIA, 2023, 164 : 74 - 93
  • [43] Suprachoroidal drug delivery: a versatile therapeutic platform
    Ciulla, Thomas A.
    Cunningham Jr, Emmett T.
    EXPERT OPINION ON DRUG DELIVERY, 2024, 21 (12) : 1705 - 1713
  • [44] Dendrimers as versatile platform in drug delivery applications
    Svenson, Sonke
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2009, 71 (03) : 445 - 462
  • [45] PASylation®: A versatile technology to extend drug delivery
    Binder, Uli
    Skerra, Arne
    CURRENT OPINION IN COLLOID & INTERFACE SCIENCE, 2017, 31 : 10 - 17
  • [46] Scleroglucan: A versatile polysaccharide for modified drug delivery
    Coviello, T
    Palleschi, A
    Grassi, M
    Matricardi, P
    Bocchinfuso, G
    Alhaique, F
    MOLECULES, 2005, 10 (01): : 6 - 33
  • [47] Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues
    Madaan, Kanika
    Kumar, Sandeep
    Poonia, Neelam
    Lather, Viney
    Pandita, Deepti
    JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2014, 6 (03): : 139 - 150
  • [48] Click Reaction in the Synthesis of Dendrimer Drug-delivery Systems
    Garcia-Alvarez, Fernando
    Martinez-Garcia, Marcos
    CURRENT MEDICINAL CHEMISTRY, 2022, 19 (19) : 3445 - 3470
  • [49] POLYMER DRUG DELIVERY SYSTEMS
    MOGILEVICH, IM
    MEIYA, NV
    KHIMIKO-FARMATSEVTICHESKII ZHURNAL, 1989, 23 (03): : 361 - 372
  • [50] In vitro and in vivo evaluation of a melamine dendrimer as a vehicle for drug delivery
    Neerman, MF
    Zhang, W
    Parrish, AR
    Simanek, EE
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 281 (1-2) : 129 - 132